August 10, 2011
The lab testing giant's clinical trials services group will work with the Murdock group at the N.C. Research Campus to develop new diagnostics, biomarker assays.
June 1, 2011
Burlington-based Laboratory Corporation of America says it has agreed to buy Canada-based Clearstone Central Laboratories.
May 18, 2011
The Burlington-based lab testing firm says the Federal Trade Commission has asked for more information about the deal.
Updated April 21, 2011
According to an internal memo, the lab testing giant is preparing to cut 146 positions from a Genzyme operation that the company acquired. The jobs reportedly will be moved to LabCorp's headquarters in Burlington.
April 7, 2011
The Burlington-based lab testing firm plans to pay cash for Orchid Cellmark, which focuses on identity testing services.
February 10, 2011
Annual revenues top $5 billion for the global laboratory testing company.
February 1, 2011
The drug testing firm publishes "Virology Report," which it says is "an unprecedented resource" for testing data.
December 6, 2010
Dierdre Connelly will be joined by LabCorp, Talecris, venture firm NEA and Holostic executives as keynote presenters.
November 18, 2010
The Federal Trade Commission has blessed the deal after an antitrust review.
October 21, 2010
The Burlington-based testing giant also raises its profit forecast for the year.
Updated September 13, 2010
Genzyme is resisting takeover attempt by Sanofi-Aventis. LabCorp, the Burlington-based global testing company, is paying cash for Genzyme Genetic in a bid to broaden reproductive, genetic, oncology and clinical trials capabilities.
July 22, 2010
The Burlington, N.C.-based lab testing giant bucks tough economy with profit of $1.46 per share. LabCorp also ups its revenue and profit guidance for the year.
April 21, 2010
The Burlington-based testing giant blames weather for having “a significant impact” on its financials.